A bit of news. They hired someone to help with regulatory affairs. TBH, I have not expected to see a whole lot of progress with the FDA, but if they can prove me wrong -- even if just a Phase I study -- it will mean a lot to the value of the company when it returns to trading. We shall see.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.